MedPath

Danger Ideation Reduction Therapyin patients with obsessive-compulsive disorder

Phase 3
Conditions
Obsessive-compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT20141108019855N10
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Diagnosis of Obsessive-Compulsive Disorder

Exclusion Criteria

having thoughts or committing suicide

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before and after treatment. Method of measurement: Beck Anxiety Inventory (BAI).;Depression. Timepoint: Before and after treatment. Method of measurement: Beck Depression Inventory (BDI).;Severity of obsession. Timepoint: Before and after treatment. Method of measurement: Yale Browne- Obsessive-Compulsive Scale (Y-BOCS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath